Company Search:
Advanced Search
Sponsored Links
GlaxoSmithKline Pakistan Limited Company Snapshot
GlaxoSmithKline Pakistan Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline Pakistan Limited with three other companies in this sector in PAKISTAN : Searle Co Ltd (2019 sales of 18.06 billion Pakistan Rupees [US$107.29 million] of which 79% was Pharmaceutical), Glaxosmithkline Consumer Healthcare Pakistan Ltd (16.32 billion Pakistan Rupees [US$96.92 million] of which 100% was Consumer HealthCare), and Abbott Laboratories (Pakistan) Ltd (30.16 billion Pakistan Rupees [US$179.13 million] of which 70% was Pharmaceutical).

Sales Analysis. During the year ended December of 2019, sales at GlaxoSmithKline Pakistan Limited were 36.58 billion Pakistan Rupees (US$217.30 million). This is an increase of 7.6% versus 2018, when the company's sales were 34.01 billion Pakistan Rupees . This was the fourth straight year of sales growth at GlaxoSmithKline Pakistan Limited.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
GlaxoSmithKline Pakistan Limited
  Stock Performance Chart for GlaxoSmithKline Pakistan Limited
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 183.98
(Figures in Pakistan Rupees )
1 Week -2.5%   13 Weeks -2.5%  
4 Weeks 9.2%   52 Weeks 113.5%  
GlaxoSmithKline Pakistan Limited Key Data:
  Ticker: GLAXO Country: Pakistan
  Exchanges: KAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 36,581,749,000
(Year Ending Jan 2020).
Employees: 1,974
  Currency: Pakistan Rupees Market Cap: 58,591,609,806
  Fiscal Yr Ends: December Shares Outstanding: 318,467,278
  Share Type: Ordinary Closely Held Shares:
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.